Clinical Trial Update: Ketamine for Depression: An MRI Study [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on ketamine for depression, including anxious depression, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxious Depression
• Major Depressive Disorder

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Depression, Anxious Depression | Phase 4 | Status: COMPLETED | Results posted: 2019-04-04